27 octubre 2014
Following induction chemotherapy, obese patients were more than twice as likely to have minimal residual disease, than non-obese patients, new research suggests. «Induction chemotherapy provides a patient’s best chance for remission or a cure,» said the principal investigator. «Our findings indicate that a patient’s obesity negatively impacts the ability of chemotherapy to kill leukemia cells, reducing the odds of survival.»
http://feeds.sciencedaily.com/~r/sciencedaily/~3/SEA4nX_OcUQ/141027100253.htm
